TANATRIL Tablet Ref.[8910] Active ingredients: Imidapril

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2014  Publisher: Mitsubishi Tanabe Pharma Europe Limited, 6<sup>th</sup> Floor, Dashwood House, 69 Old Broad Street, London, EC2M 1QS, United Kingdom

Product name and form

Tanatril 5 mg tablets.

Pharmaceutical Form


Off-white oblong biconvex tablets with a plane edge, scored on both sides.

The tablet can be divided into equal doses.

Qualitative and quantitative composition

Imidapril hydrochloride 5 mg.

Excipient with known effect: Lactose, 54 mg per tablet.

For the full list of excipients, see section 6.1

Active Ingredient Description

The hypotensive effect of imidapril in hypertension appears to result primarily from the suppression of the plasma renin-angiotensin-aldosterone system.

List of Excipients

Calcium hydrogen phosphate, anhydrous
Maize starch, pregelatinised
Lactose monohydrate
Croscarmellose sodium
Glycerol distearate

Pack sizes and marketing

Aluminium/aluminium or PVDC/aluminium – Blister with 5, 7 and 10 tablets.

Packs with 7, 10, 14, 15, 20, 28, 30, 50, 56, 84, 90, 100, and 1000 tablets

Not all packaging material or pack sizes may be marketed.

Marketing authorization holder

Mitsubishi Tanabe Pharma Europe Limited, 6th Floor, Dashwood House, 69 Old Broad Street, London, EC2M 1QS, United Kingdom

Marketing authorization dates and numbers

PL 20012/0004



Drug Countries
TANATRIL Austria, Hong Kong, Japan, Poland, Singapore, Tunisia, Turkey, United Kingdom

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.